1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Peptide Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Peptide Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Peptide Vaccine by Country/Region, 2017, 2022 & 2028 2.2 Peptide Vaccine Segment by Type 2.2.1 Solution Phase Synthesis (SPS) 2.2.2 Solid Phase Peptide Synthesis (SPPS) 2.3 Peptide Vaccine Sales by Type 2.3.1 Global Peptide Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global Peptide Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global Peptide Vaccine Sale Price by Type (2017-2022) 2.4 Peptide Vaccine Segment by Application 2.4.1 Prostate Cancer 2.4.2 Breast Cancer 2.4.3 Gastric Cancer 2.4.4 Lung Cancer 2.4.5 Pancreatic Cancer 2.4.6 Others 2.5 Peptide Vaccine Sales by Application 2.5.1 Global Peptide Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global Peptide Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global Peptide Vaccine Sale Price by Application (2017-2022) 3 Global Peptide Vaccine by Company 3.1 Global Peptide Vaccine Breakdown Data by Company 3.1.1 Global Peptide Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global Peptide Vaccine Sales Market Share by Company (2020-2022) 3.2 Global Peptide Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global Peptide Vaccine Revenue by Company (2020-2022) 3.2.2 Global Peptide Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global Peptide Vaccine Sale Price by Company 3.4 Key Manufacturers Peptide Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Peptide Vaccine Product Location Distribution 3.4.2 Players Peptide Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Peptide Vaccine by Geographic Region 4.1 World Historic Peptide Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global Peptide Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Peptide Vaccine Annual Revenue by Geographic Region 4.2 World Historic Peptide Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global Peptide Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global Peptide Vaccine Annual Revenue by Country/Region 4.3 Americas Peptide Vaccine Sales Growth 4.4 APAC Peptide Vaccine Sales Growth 4.5 Europe Peptide Vaccine Sales Growth 4.6 Middle East & Africa Peptide Vaccine Sales Growth 5 Americas 5.1 Americas Peptide Vaccine Sales by Country 5.1.1 Americas Peptide Vaccine Sales by Country (2017-2022) 5.1.2 Americas Peptide Vaccine Revenue by Country (2017-2022) 5.2 Americas Peptide Vaccine Sales by Type 5.3 Americas Peptide Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Peptide Vaccine Sales by Region 6.1.1 APAC Peptide Vaccine Sales by Region (2017-2022) 6.1.2 APAC Peptide Vaccine Revenue by Region (2017-2022) 6.2 APAC Peptide Vaccine Sales by Type 6.3 APAC Peptide Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Peptide Vaccine by Country 7.1.1 Europe Peptide Vaccine Sales by Country (2017-2022) 7.1.2 Europe Peptide Vaccine Revenue by Country (2017-2022) 7.2 Europe Peptide Vaccine Sales by Type 7.3 Europe Peptide Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Peptide Vaccine by Country 8.1.1 Middle East & Africa Peptide Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa Peptide Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa Peptide Vaccine Sales by Type 8.3 Middle East & Africa Peptide Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Peptide Vaccine 10.3 Manufacturing Process Analysis of Peptide Vaccine 10.4 Industry Chain Structure of Peptide Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Peptide Vaccine Distributors 11.3 Peptide Vaccine Customer 12 World Forecast Review for Peptide Vaccine by Geographic Region 12.1 Global Peptide Vaccine Market Size Forecast by Region 12.1.1 Global Peptide Vaccine Forecast by Region (2023-2028) 12.1.2 Global Peptide Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Peptide Vaccine Forecast by Type 12.7 Global Peptide Vaccine Forecast by Application 13 Key Players Analysis 13.1 Anergis 13.1.1 Anergis Company Information 13.1.2 Anergis Peptide Vaccine Product Offered 13.1.3 Anergis Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Anergis Main Business Overview 13.1.5 Anergis Latest Developments 13.2 Antigen Express 13.2.1 Antigen Express Company Information 13.2.2 Antigen Express Peptide Vaccine Product Offered 13.2.3 Antigen Express Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Antigen Express Main Business Overview 13.2.5 Antigen Express Latest Developments 13.3 Apitope Technology 13.3.1 Apitope Technology Company Information 13.3.2 Apitope Technology Peptide Vaccine Product Offered 13.3.3 Apitope Technology Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 Apitope Technology Main Business Overview 13.3.5 Apitope Technology Latest Developments 13.4 Artificial Cell Technologies 13.4.1 Artificial Cell Technologies Company Information 13.4.2 Artificial Cell Technologies Peptide Vaccine Product Offered 13.4.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Artificial Cell Technologies Main Business Overview 13.4.5 Artificial Cell Technologies Latest Developments 13.5 Benovus Bio 13.5.1 Benovus Bio Company Information 13.5.2 Benovus Bio Peptide Vaccine Product Offered 13.5.3 Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Benovus Bio Main Business Overview 13.5.5 Benovus Bio Latest Developments 13.6 Celgene Corporation 13.6.1 Celgene Corporation Company Information 13.6.2 Celgene Corporation Peptide Vaccine Product Offered 13.6.3 Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Celgene Corporation Main Business Overview 13.6.5 Celgene Corporation Latest Developments 13.7 Immatics biotechnologies 13.7.1 Immatics biotechnologies Company Information 13.7.2 Immatics biotechnologies Peptide Vaccine Product Offered 13.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Immatics biotechnologies Main Business Overview 13.7.5 Immatics biotechnologies Latest Developments 13.8 Merck 13.8.1 Merck Company Information 13.8.2 Merck Peptide Vaccine Product Offered 13.8.3 Merck Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Merck Main Business Overview 13.8.5 Merck Latest Developments 13.9 ImmunoCellular Therapeutics 13.9.1 ImmunoCellular Therapeutics Company Information 13.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Offered 13.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 ImmunoCellular Therapeutics Main Business Overview 13.9.5 ImmunoCellular Therapeutics Latest Developments 13.10 ISA Pharmaceuticals 13.10.1 ISA Pharmaceuticals Company Information 13.10.2 ISA Pharmaceuticals Peptide Vaccine Product Offered 13.10.3 ISA Pharmaceuticals Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 ISA Pharmaceuticals Main Business Overview 13.10.5 ISA Pharmaceuticals Latest Developments 13.11 Lytix Biopharma 13.11.1 Lytix Biopharma Company Information 13.11.2 Lytix Biopharma Peptide Vaccine Product Offered 13.11.3 Lytix Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Lytix Biopharma Main Business Overview 13.11.5 Lytix Biopharma Latest Developments 13.12 Spotlight Innovation 13.12.1 Spotlight Innovation Company Information 13.12.2 Spotlight Innovation Peptide Vaccine Product Offered 13.12.3 Spotlight Innovation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Spotlight Innovation Main Business Overview 13.12.5 Spotlight Innovation Latest Developments 13.13 OncoTherapy Science 13.13.1 OncoTherapy Science Company Information 13.13.2 OncoTherapy Science Peptide Vaccine Product Offered 13.13.3 OncoTherapy Science Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 OncoTherapy Science Main Business Overview 13.13.5 OncoTherapy Science Latest Developments 13.14 Peptech 13.14.1 Peptech Company Information 13.14.2 Peptech Peptide Vaccine Product Offered 13.14.3 Peptech Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 Peptech Main Business Overview 13.14.5 Peptech Latest Developments 13.15 Pharmasyntez 13.15.1 Pharmasyntez Company Information 13.15.2 Pharmasyntez Peptide Vaccine Product Offered 13.15.3 Pharmasyntez Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.15.4 Pharmasyntez Main Business Overview 13.15.5 Pharmasyntez Latest Developments 13.16 Sumitomo Dainippon Pharma 13.16.1 Sumitomo Dainippon Pharma Company Information 13.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Offered 13.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.16.4 Sumitomo Dainippon Pharma Main Business Overview 13.16.5 Sumitomo Dainippon Pharma Latest Developments 13.17 TapImmune 13.17.1 TapImmune Company Information 13.17.2 TapImmune Peptide Vaccine Product Offered 13.17.3 TapImmune Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.17.4 TapImmune Main Business Overview 13.17.5 TapImmune Latest Developments 13.18 Targovax 13.18.1 Targovax Company Information 13.18.2 Targovax Peptide Vaccine Product Offered 13.18.3 Targovax Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.18.4 Targovax Main Business Overview 13.18.5 Targovax Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Peptide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Peptide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Solution Phase Synthesis (SPS) Table 4. Major Players of Solid Phase Peptide Synthesis (SPPS) Table 5. Global Peptide Vaccine Sales by Type (2017-2022) & (K Units) Table 6. Global Peptide Vaccine Sales Market Share by Type (2017-2022) Table 7. Global Peptide Vaccine Revenue by Type (2017-2022) & ($ million) Table 8. Global Peptide Vaccine Revenue Market Share by Type (2017-2022) Table 9. Global Peptide Vaccine Sale Price by Type (2017-2022) & (US$/Unit) Table 10. Global Peptide Vaccine Sales by Application (2017-2022) & (K Units) Table 11. Global Peptide Vaccine Sales Market Share by Application (2017-2022) Table 12. Global Peptide Vaccine Revenue by Application (2017-2022) Table 13. Global Peptide Vaccine Revenue Market Share by Application (2017-2022) Table 14. Global Peptide Vaccine Sale Price by Application (2017-2022) & (US$/Unit) Table 15. Global Peptide Vaccine Sales by Company (2020-2022) & (K Units) Table 16. Global Peptide Vaccine Sales Market Share by Company (2020-2022) Table 17. Global Peptide Vaccine Revenue by Company (2020-2022) ($ Millions) Table 18. Global Peptide Vaccine Revenue Market Share by Company (2020-2022) Table 19. Global Peptide Vaccine Sale Price by Company (2020-2022) & (US$/Unit) Table 20. Key Manufacturers Peptide Vaccine Producing Area Distribution and Sales Area Table 21. Players Peptide Vaccine Products Offered Table 22. Peptide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Peptide Vaccine Sales by Geographic Region (2017-2022) & (K Units) Table 26. Global Peptide Vaccine Sales Market Share Geographic Region (2017-2022) Table 27. Global Peptide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Peptide Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Peptide Vaccine Sales by Country/Region (2017-2022) & (K Units) Table 30. Global Peptide Vaccine Sales Market Share by Country/Region (2017-2022) Table 31. Global Peptide Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Peptide Vaccine Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Peptide Vaccine Sales by Country (2017-2022) & (K Units) Table 34. Americas Peptide Vaccine Sales Market Share by Country (2017-2022) Table 35. Americas Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Peptide Vaccine Revenue Market Share by Country (2017-2022) Table 37. Americas Peptide Vaccine Sales by Type (2017-2022) & (K Units) Table 38. Americas Peptide Vaccine Sales Market Share by Type (2017-2022) Table 39. Americas Peptide Vaccine Sales by Application (2017-2022) & (K Units) Table 40. Americas Peptide Vaccine Sales Market Share by Application (2017-2022) Table 41. APAC Peptide Vaccine Sales by Region (2017-2022) & (K Units) Table 42. APAC Peptide Vaccine Sales Market Share by Region (2017-2022) Table 43. APAC Peptide Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Peptide Vaccine Revenue Market Share by Region (2017-2022) Table 45. APAC Peptide Vaccine Sales by Type (2017-2022) & (K Units) Table 46. APAC Peptide Vaccine Sales Market Share by Type (2017-2022) Table 47. APAC Peptide Vaccine Sales by Application (2017-2022) & (K Units) Table 48. APAC Peptide Vaccine Sales Market Share by Application (2017-2022) Table 49. Europe Peptide Vaccine Sales by Country (2017-2022) & (K Units) Table 50. Europe Peptide Vaccine Sales Market Share by Country (2017-2022) Table 51. Europe Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Peptide Vaccine Revenue Market Share by Country (2017-2022) Table 53. Europe Peptide Vaccine Sales by Type (2017-2022) & (K Units) Table 54. Europe Peptide Vaccine Sales Market Share by Type (2017-2022) Table 55. Europe Peptide Vaccine Sales by Application (2017-2022) & (K Units) Table 56. Europe Peptide Vaccine Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Peptide Vaccine Sales by Country (2017-2022) & (K Units) Table 58. Middle East & Africa Peptide Vaccine Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Peptide Vaccine Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Peptide Vaccine Sales by Type (2017-2022) & (K Units) Table 62. Middle East & Africa Peptide Vaccine Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Peptide Vaccine Sales by Application (2017-2022) & (K Units) Table 64. Middle East & Africa Peptide Vaccine Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Peptide Vaccine Table 66. Key Market Challenges & Risks of Peptide Vaccine Table 67. Key Industry Trends of Peptide Vaccine Table 68. Peptide Vaccine Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Peptide Vaccine Distributors List Table 71. Peptide Vaccine Customer List Table 72. Global Peptide Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 73. Global Peptide Vaccine Sales Market Forecast by Region Table 74. Global Peptide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Peptide Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 77. Americas Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Peptide Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 79. APAC Peptide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 81. Europe Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 83. Middle East & Africa Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Peptide Vaccine Sales Forecast by Type (2023-2028) & (K Units) Table 85. Global Peptide Vaccine Sales Market Share Forecast by Type (2023-2028) Table 86. Global Peptide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Peptide Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Peptide Vaccine Sales Forecast by Application (2023-2028) & (K Units) Table 89. Global Peptide Vaccine Sales Market Share Forecast by Application (2023-2028) Table 90. Global Peptide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Peptide Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 92. Anergis Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. Anergis Peptide Vaccine Product Offered Table 94. Anergis Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 95. Anergis Main Business Table 96. Anergis Latest Developments Table 97. Antigen Express Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. Antigen Express Peptide Vaccine Product Offered Table 99. Antigen Express Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 100. Antigen Express Main Business Table 101. Antigen Express Latest Developments Table 102. Apitope Technology Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. Apitope Technology Peptide Vaccine Product Offered Table 104. Apitope Technology Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 105. Apitope Technology Main Business Table 106. Apitope Technology Latest Developments Table 107. Artificial Cell Technologies Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Artificial Cell Technologies Peptide Vaccine Product Offered Table 109. Artificial Cell Technologies Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 110. Artificial Cell Technologies Main Business Table 111. Artificial Cell Technologies Latest Developments Table 112. Benovus Bio Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 113. Benovus Bio Peptide Vaccine Product Offered Table 114. Benovus Bio Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 115. Benovus Bio Main Business Table 116. Benovus Bio Latest Developments Table 117. Celgene Corporation Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 118. Celgene Corporation Peptide Vaccine Product Offered Table 119. Celgene Corporation Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 120. Celgene Corporation Main Business Table 121. Celgene Corporation Latest Developments Table 122. Immatics biotechnologies Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 123. Immatics biotechnologies Peptide Vaccine Product Offered Table 124. Immatics biotechnologies Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 125. Immatics biotechnologies Main Business Table 126. Immatics biotechnologies Latest Developments Table 127. Merck Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 128. Merck Peptide Vaccine Product Offered Table 129. Merck Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 130. Merck Main Business Table 131. Merck Latest Developments Table 132. ImmunoCellular Therapeutics Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 133. ImmunoCellular Therapeutics Peptide Vaccine Product Offered Table 134. ImmunoCellular Therapeutics Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 135. ImmunoCellular Therapeutics Main Business Table 136. ImmunoCellular Therapeutics Latest Developments Table 137. ISA Pharmaceuticals Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 138. ISA Pharmaceuticals Peptide Vaccine Product Offered Table 139. ISA Pharmaceuticals Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 140. ISA Pharmaceuticals Main Business Table 141. ISA Pharmaceuticals Latest Developments Table 142. Lytix Biopharma Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 143. Lytix Biopharma Peptide Vaccine Product Offered Table 144. Lytix Biopharma Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 145. Lytix Biopharma Main Business Table 146. Lytix Biopharma Latest Developments Table 147. Spotlight Innovation Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 148. Spotlight Innovation Peptide Vaccine Product Offered Table 149. Spotlight Innovation Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 150. Spotlight Innovation Main Business Table 151. Spotlight Innovation Latest Developments Table 152. OncoTherapy Science Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 153. OncoTherapy Science Peptide Vaccine Product Offered Table 154. OncoTherapy Science Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 155. OncoTherapy Science Main Business Table 156. OncoTherapy Science Latest Developments Table 157. Peptech Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 158. Peptech Peptide Vaccine Product Offered Table 159. Peptech Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 160. Peptech Main Business Table 161. Peptech Latest Developments Table 162. Pharmasyntez Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 163. Pharmasyntez Peptide Vaccine Product Offered Table 164. Pharmasyntez Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 165. Pharmasyntez Main Business Table 166. Pharmasyntez Latest Developments Table 167. Sumitomo Dainippon Pharma Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 168. Sumitomo Dainippon Pharma Peptide Vaccine Product Offered Table 169. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 170. Sumitomo Dainippon Pharma Main Business Table 171. Sumitomo Dainippon Pharma Latest Developments Table 172. TapImmune Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 173. TapImmune Peptide Vaccine Product Offered Table 174. TapImmune Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 175. TapImmune Main Business Table 176. TapImmune Latest Developments Table 177. Targovax Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors Table 178. Targovax Peptide Vaccine Product Offered Table 179. Targovax Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 180. Targovax Main Business Table 181. Targovax Latest Developments List of Figures Figure 1. Picture of Peptide Vaccine Figure 2. Peptide Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Peptide Vaccine Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Peptide Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Peptide Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Solution Phase Synthesis (SPS) Figure 10. Product Picture of Solid Phase Peptide Synthesis (SPPS) Figure 11. Global Peptide Vaccine Sales Market Share by Type in 2021 Figure 12. Global Peptide Vaccine Revenue Market Share by Type (2017-2022) Figure 13. Peptide Vaccine Consumed in Prostate Cancer Figure 14. Global Peptide Vaccine Market: Prostate Cancer (2017-2022) & (K Units) Figure 15. Peptide Vaccine Consumed in Breast Cancer Figure 16. Global Peptide Vaccine Market: Breast Cancer (2017-2022) & (K Units) Figure 17. Peptide Vaccine Consumed in Gastric Cancer Figure 18. Global Peptide Vaccine Market: Gastric Cancer (2017-2022) & (K Units) Figure 19. Peptide Vaccine Consumed in Lung Cancer Figure 20. Global Peptide Vaccine Market: Lung Cancer (2017-2022) & (K Units) Figure 21. Peptide Vaccine Consumed in Pancreatic Cancer Figure 22. Global Peptide Vaccine Market: Pancreatic Cancer (2017-2022) & (K Units) Figure 23. Peptide Vaccine Consumed in Others Figure 24. Global Peptide Vaccine Market: Others (2017-2022) & (K Units) Figure 25. Global Peptide Vaccine Sales Market Share by Application (2017-2022) Figure 26. Global Peptide Vaccine Revenue Market Share by Application in 2021 Figure 27. Peptide Vaccine Revenue Market by Company in 2021 ($ Million) Figure 28. Global Peptide Vaccine Revenue Market Share by Company in 2021 Figure 29. Global Peptide Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 30. Global Peptide Vaccine Revenue Market Share by Geographic Region in 2021 Figure 31. Global Peptide Vaccine Sales Market Share by Region (2017-2022) Figure 32. Global Peptide Vaccine Revenue Market Share by Country/Region in 2021 Figure 33. Americas Peptide Vaccine Sales 2017-2022 (K Units) Figure 34. Americas Peptide Vaccine Revenue 2017-2022 ($ Millions) Figure 35. APAC Peptide Vaccine Sales 2017-2022 (K Units) Figure 36. APAC Peptide Vaccine Revenue 2017-2022 ($ Millions) Figure 37. Europe Peptide Vaccine Sales 2017-2022 (K Units) Figure 38. Europe Peptide Vaccine Revenue 2017-2022 ($ Millions) Figure 39. Middle East & Africa Peptide Vaccine Sales 2017-2022 (K Units) Figure 40. Middle East & Africa Peptide Vaccine Revenue 2017-2022 ($ Millions) Figure 41. Americas Peptide Vaccine Sales Market Share by Country in 2021 Figure 42. Americas Peptide Vaccine Revenue Market Share by Country in 2021 Figure 43. United States Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 44. Canada Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. Mexico Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. Brazil Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. APAC Peptide Vaccine Sales Market Share by Region in 2021 Figure 48. APAC Peptide Vaccine Revenue Market Share by Regions in 2021 Figure 49. China Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. Japan Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 51. South Korea Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 52. Southeast Asia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. India Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. Australia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 55. Europe Peptide Vaccine Sales Market Share by Country in 2021 Figure 56. Europe Peptide Vaccine Revenue Market Share by Country in 2021 Figure 57. Germany Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 58. France Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 59. UK Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. Italy Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Russia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 62. Middle East & Africa Peptide Vaccine Sales Market Share by Country in 2021 Figure 63. Middle East & Africa Peptide Vaccine Revenue Market Share by Country in 2021 Figure 64. Egypt Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 65. South Africa Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 66. Israel Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 67. Turkey Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 68. GCC Country Peptide Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 69. Manufacturing Cost Structure Analysis of Peptide Vaccine in 2021 Figure 70. Manufacturing Process Analysis of Peptide Vaccine Figure 71. Industry Chain Structure of Peptide Vaccine Figure 72. Channels of Distribution Figure 73. Distributors Profiles